Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
BMP5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
USP32 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
SMCHD1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LEXM - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PLD5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TAOK1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
P3H1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
ZNF561 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KDM5A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BAZ1B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC7A11-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C4orf3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SCCPDH - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
COL4A3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101927830 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PTPN21 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on